Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve

European Heart Journal

Volumn 29, Issue 6, 2008, Pages 726-732

  Koo, Bon Kwon ^a   Park, Kyung Woo ^a   Kang, Hyun Jae ^a   Cho, Young Seok ^b   Chung, Woo Young ^b   Youn, Tae Jin ^b   Chae, In Ho ^b   Choi, Dong Ju ^b   Tahk, Seung Jae ^c   Oh, Byung Hee ^a   Park, Young Bae ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Angioplasty; Bifurcation; Physiology; Restenosis; Stents

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS;

BALLOON DILATATION; CORONARY STENOSIS; DEATH, SUDDEN, CARDIAC; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; TREATMENT OUTCOME;

EID: 41149132167     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn045     Document Type: Article

References (22)

1. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-1249.
2. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, Delgado A, Ojeda S, Melian F, Herrador J, Urena I, Burgos L. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. Am Heart J 2004;148:857-864.
3. Ge L, Tsagalou E, Iakovou I, Sangiorgi GM, Corvaja N, Airoldi F, Chieffo A, Montorfano M, Michev I, Colombo A. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005;95:757-760.
4. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemela M, Kervinen K, Jensen JS, Galloe A, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S, Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L; Nordic PCI Study Group. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions. The Nordic bifurcation study. Circulation 2006;114:1955-1961.
5. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, Lee C, Degertekin M, Hofma SH, Sianos G, McFadden E, Smits PC, van der Giessen WJ, de Feyter P, van Domburg DT, Serruys PW. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004;91:115-118.
6. Ge L, Iakovou I, Cosgrave J, Agostoni P, Airoldi F, Sangiorgi GM, Michev I, Chieffo A, Montorfano M, Carlino M, Corvaja N, Colombo A. Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting. Heart 2006;92:371-376.
7. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, Premchand RK, Guillard N, Piechaud JF. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000;49:274-283.
8. Yamashita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, Corvaja N, Albiero R, Finci L, Di Mario C, Tobis JM, Colombo A. Bifurcation lesions: two stents versus one stent-immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-1151.
9. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR Jr. Immediate and long-term outcomes of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000;35:1145-1151.
10. Ziaee A, Parham WA, Hermann SC, Stewart RE, Lim MJ, Kern MJ. Lack of relation between imaging and physiology in ostial coronary artery narrowings. Am J Cardiol 2004;93:1404-1407.
11. Bech GJ, Droste H, Pijls NH, De Bruyne B, Bonnier HJ, Michels HR, Peels KH, Koolen JJ. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart 2001;86:547-552.
12. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Tahk SJ. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005;46:633-637.
13. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after PTCA. Circulation 1993;87:1354-1367.
14. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurement and exercise-induced myocardial ischemia. Circulation 1995;92:39-46.
15. Pijls NH, De Bruyne B, Peels K, van der Voort PH, Bonnier HJ, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med 1996;334:1703- 1708.
16. Koo BK, Kim CH, Na SH, Youn TJ, Chae IH, Choi DJ, Kim HS, Lee MM, Oh BH, Park YB, Choi YS, Tahk SJ. Intracoronary continuous adenosine infusion. Circ J 2005;69:908-912.
17. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
18. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
19. Richter Y, Groothuis A, Seifert P, Edelman ER. Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. J Clin Invest 2004;113:1607-1614.
20. van't Veer M, Pijls NH, Aarnoudse W, Koolen JJ, van de Vosse FN. Evaluation of the haemodynamic characteristics of drug-eluting stents at implantation and at follow up. Eur Heart J 2006;27:1811-1817.
21. Thomas M, Hildick-Smith D, Louvard Y, Albiero R, Darremont O, Stankovic G, Pan M, Legrand V, De Bruyne B, Lefevre T. Percutaneous coronary intervention for bifurcation disease. A consensus view from the first meeting of the European bifurcation club. Euro-Interv 2006;2:149-153.
22. Goktekin O, Kaplan S, Dimopoulos K, Barlis P, Tanigawa J, Vatankulu MA, Koning G, Tuinenburg JC, Di Mario C. A new quantitative analysis system for the evaluation of coronary bifurcation lesions: comparison with current conventional methods. Catheter Cardiovasc Interv 2007;69:172-180.